Scoping reports

The scoping report defines the research question in concrete terms and develops the methodology for the assessment.

The scoping reports that have been completed are shown below.

Procedure

The FOPH prepares a pre-scope in the form of an initial analysis and a precise definition of the questions asked in relation to the selected theme. On this basis the contractor drafts the actual scoping report. This is submitted to a group of reviewers consisting offour to five independent experts who assess the scientific quality of the report. The report is then submitted to stakeholders and finalised.

Olmesartan Mono- and Combination Therapies in Patients with Essential Hypertension

The aim of the Health Technology Assessment (HTA) is to evaluate the efficacy, effectiveness, safety, cost-effectiveness and budget impact of olmesartan mono- and combination therapies compared to all other sartan mono- and combination therapies available in Switzerland in patients with essential hypertension.

Treatment of non-erosive gastroesophageal reflux disease patients with proton pump inhibitors

The aim of the Health Technology Assessment (HTA) is to evaluate the efficacy, effectiveness, safety, cost-effectiveness and budget impact of long-term continuous proton pump inhibitor (PPI) therapy compared to long-term on-demand PPI therapy in patients with non-erosive reflux disease (NERD) and patients with uninvestigated gastroesophageal reflux disease (GERD).  

Chondroitin Sulfate in Osteoarthritis

The objective of the HTA is to compare the safety, efficacy and effectiveness of chondroitin sulfate with placebo, on-demand analgesics and anti-inflammatory treatments in patients with osteoarthritis of the hands, knees and hips. In addition, the cost-effectiveness and budgetary impact of chondroitin sulfate warrants investigation.

Removal of osteosynthesis devices (e.g. screws, plates, nails and wires) used to treat bone fractures (2016)

Research questions: How does the removal of osteosynthesis material in patients without medical indication (elective or routine removal) affect complication rates, clinical outcomes, health-related quality of life and cost-effectiveness outcomes compared to retention of the osteosynthesis material?

Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus
type 2 (2016)

Research questions:

  • How does a decrease in HbA1c levels affect clinical endpoints?
  • What is the safety profile of self-measurement of blood glucose?
  • What is the cost-effectiveness of the different possible variations in self-measurement of blood glucose?

Knee arthroscopy for the treatment of degenerative changes (2015)

Research question: What is the benefit of knee arthroscopy for patients with symptoms resulting from degenerative changes of the knee in general compared with non-invasive forms of therapy?

Iron replacement therapy for iron deficiency without anaemia (2015)

Issue:

  1. The connection between iron deficiency without anaemia and non-haematological clinical disorders
  2. Therapeutic need for and efficacy of iron replacement therapy for iron deficiency without anaemia

Last modification 01.10.2019

Top of page

Contact

Federal Office of Public Health FOPH
Division of Health Care Services
Health Technology Assessment Section
Schwarzenburgstrasse 157
3003 Berne
Switzerland
Tel. +41 58 462 21 11
E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-bezeichnung-der-leistungen/re-evaluation-hta/scoping-berichte.html